5 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32980960 | MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines. | 2021 Jan | 4 |
2 | 33497758 | Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer. | 2021 Apr | 1 |
3 | 34164713 | Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors. | 2021 Oct | 1 |
4 | 34804015 | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? | 2021 | 2 |
5 | 32716114 | A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma. | 2020 Oct | 3 |